MedTrace Logo

An Intervention Programme to Reduce Cognitive Impairment Due to Cancer

NCT02581709 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-12-22

No results posted yet for this study

Summary

The goal of this research study is to test the feasibility of an intervention programme to reduce cognitive impairment due to cancer treatment. The investigators want to find out how acceptable the intervention and procedures are for cancer patients.

Conditions

  • Breast Neoplasms
  • Colorectal Neoplasms

Interventions

BEHAVIORAL

Countering cognitive impairment

The intervention will include education about cancer-related cognitive impairment, instruction on relaxation techniques, compensatory techniques, goal-setting and lifestyle advice. Each session will last between 90 and 120 minutes, once a week for six weeks. The intervention will be delivered in a group setting, in a non-clinical environment by the investigators.

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    collaborator OTHER

  • Cancer Research Network

    collaborator OTHER

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Michael Donnelly, PhD · Queen's University, Belfast

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02581709 on ClinicalTrials.gov